Published in Neuropathology on August 01, 2006
Interleukin 18 in the CNS. J Neuroinflammation (2010) 1.26
Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases. Mini Rev Med Chem (2009) 1.03
Pro-inflammatory interleukin-18 increases Alzheimer's disease-associated amyloid-β production in human neuron-like cells. J Neuroinflammation (2012) 1.03
Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview. Mol Neurobiol (2014) 0.98
The role of inflammasome in Alzheimer's disease. Ageing Res Rev (2014) 0.95
Rodent models of neuroinflammation for Alzheimer's disease. J Neuroinflammation (2015) 0.87
Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2007) 0.84
Altered expression of claudin family proteins in Alzheimer's disease and vascular dementia brains. J Cell Mol Med (2010) 0.82
Simvastatin restored vascular reactivity, endothelial function and reduced string vessel pathology in a mouse model of cerebrovascular disease. J Cereb Blood Flow Metab (2015) 0.80
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease. Mol Neurodegener (2016) 0.79
The Distinct Role of ADAM17 in APP Proteolysis and Microglial Activation Related to Alzheimer's Disease. Cell Mol Neurobiol (2015) 0.76
The Serum Levels of Resistin and Its Relationship with Other Proinflammatory Cytokines in Patients with Alzheimer's Disease. Clin Psychopharmacol Neurosci (2017) 0.75
Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease. J Neurochem (2015) 0.75
Interleukin-18 -137 G/C and -607 C/A polymorphisms and Alzheimer's disease risk: a meta-analysis. Neurol Sci (2016) 0.75
Serum markers of hepatocellular carcinoma. Dig Dis Sci (2010) 1.76
The management of tumor lysis syndrome. Nat Clin Pract Oncol (2006) 1.60
Study on unrecognized peripheral arterial disease (PAD) by ankle/brachial index and arterial comorbidity in Catania, Sicily, Italy. Angiology (2010) 1.56
Molecular mechanisms involved in NAFLD progression. J Mol Med (Berl) (2009) 1.50
Prediction of the response to citalopram and reboxetine in post-stroke depressed patients. Psychopharmacology (Berl) (2003) 1.49
Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology (2004) 1.46
Supercentenarians: the oldest people in the world. Indian J Med Res (2010) 1.44
Metal fume fever. Lancet (2013) 1.43
The immune response to Plasmodium falciparum malaria. Lancet Infect Dis (2002) 1.42
Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. Int J Med Sci (2007) 1.33
Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome. Dig Dis Sci (2007) 1.18
B cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev (2003) 1.17
Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. J Hepatol (2005) 1.09
Plasma levels of interleukin-12 (IL-12), interleukin-18 (IL-18) and transforming growth factor beta (TGF-beta) in Plasmodium falciparum malaria. Eur Cytokine Netw (2003) 1.05
Systemic therapies in hepatocellular carcinoma: present and future. Future Oncol (2013) 1.03
Increased levels of interleukin-12 in Plasmodium falciparum malaria: correlation with the severity of disease. Parasite Immunol (2002) 0.98
L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol (2011) 0.98
The role of immunity in elderly cancer. Crit Rev Oncol Hematol (2009) 0.98
Toxic hepatitis in occupational exposure to solvents. World J Gastroenterol (2012) 0.98
Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. Eur J Neurosci (2006) 0.94
L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial. Am J Clin Nutr (2007) 0.94
The extreme longevity: the state of the art in Italy. Exp Gerontol (2007) 0.93
Plasma lipid composition and LDL oxidation. Clin Chem Lab Med (2003) 0.92
Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution. Am J Gastroenterol (2006) 0.92
HIV RNA suppression and immune restoration: can we do better? Clin Dev Immunol (2012) 0.92
The physiopathology of lipoprotein (a). Front Biosci (Schol Ed) (2010) 0.89
Lipoprotein(a) serum levels in diabetic patients with retinopathy. Biomed Res Int (2013) 0.89
L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin Nutr (2008) 0.89
Neurotoxicity of acrylamide in exposed workers. Int J Environ Res Public Health (2013) 0.89
L-carnitine decreases severity and type of fatigue induced by interferon-alpha in the treatment of patients with hepatitis C. Neuropsychobiology (2003) 0.88
Oxidized LDL antibodies (OLAB) in patients with beta-thalassemia major. J Atheroscler Thromb (2002) 0.88
Human chitotriosidase polymorphism is associated with human longevity in Mediterranean nonagenarians and centenarians. J Hum Genet (2009) 0.88
Rare benign tumors of the liver: still rare? J Gastrointest Cancer (2014) 0.88
The supplementation of acetyl-L-carnitine decreases fatigue and increases quality of life in patients with hepatitis C treated with pegylated interferon-α 2b plus ribavirin. J Interferon Cytokine Res (2011) 0.88
Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol (2011) 0.87
New possibilities of treatment for panic attacks in elderly patients: escitalopram versus citalopram. J Clin Psychopharmacol (2006) 0.87
L-carnitine treatment reduces steatosis in patients with chronic hepatitis C treated with alpha-interferon and ribavirin. Dig Dis Sci (2007) 0.87
Chromogranin A (CgA) serum level as a marker of progression in hepatocellular carcinoma (HCC) of elderly patients. Arch Gerontol Geriatr (2009) 0.87
Serum markers of cutaneous melanoma. Front Biosci (Elite Ed) (2010) 0.86
A single dose of rasburicase in elderly patients with hyperuricaemia reduces serum uric acid levels and improves renal function. Expert Opin Pharmacother (2009) 0.86
Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue. Arch Gerontol Geriatr (2007) 0.86
Revision of the ADA-classification of diabetes mellitus type 2 (DMT2): the importance of maturity onset diabetes (MOD), and senile diabetes (DS). Arch Gerontol Geriatr (2010) 0.86
Stress in centenarians. Arch Gerontol Geriatr (2008) 0.86
Long-term persistence of seroprotection by hepatitis B vaccination in healthcare workers of southern Italy. Hepat Mon (2012) 0.85
A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mesenchymal stem cells. J Neurosci Res (2008) 0.85
An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study. Arch Gerontol Geriatr (2004) 0.84
Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue. Drugs Aging (2003) 0.84
The chromogranin-A (CgA) in prostate cancer. Arch Gerontol Geriatr (2005) 0.84
Rasburicase for the treatment of tumor lysis in hematological malignancies. Expert Rev Hematol (2012) 0.83
Consensus Document on substitution therapy with testosterone in hypoandrogenic elderly men. Aging Clin Exp Res (2002) 0.83
Elevated plasma total homocysteine in centenarians. Clin Chem Lab Med (2004) 0.83
The role of diet in gastric cancer: still an open question. Front Biosci (Landmark Ed) (2012) 0.83
Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects. Cytokine (2012) 0.83
Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr (2011) 0.82
Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients. Hepat Mon (2011) 0.82
The role of micronutrients in the diet of HIV-1-infected individuals. Front Biosci (Elite Ed) (2012) 0.82
Carbohydrate 19.9 antigen serum levels in liver disease. Biomed Res Int (2013) 0.82
Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus. Expert Opin Pharmacother (2009) 0.82
The health-care in the extreme longevity. Arch Gerontol Geriatr (2008) 0.81
Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer. Arch Gerontol Geriatr (2008) 0.81
A musician's dystonia. Lancet (2012) 0.80
Pathogenesis of senile diabetes. Indian J Med Res (2008) 0.80
Value and significance of new diagnostic criteria of diabetes mellitus in older people. Arch Gerontol Geriatr (2006) 0.80
Cytokine serum profile in a group of Sicilian nonagenarians. J Immunoassay Immunochem (2012) 0.80
The metabolic syndrome (MS) in the elderly: considerations on the diagnostic criteria of the International Diabetes Federation (IDF) and some proposed modifications. Arch Gerontol Geriatr (2008) 0.80
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders. Oncol Rep (2006) 0.80
Risk of hepatocellular carcinoma in workers exposed to chemicals. Hepat Mon (2012) 0.80
Serum bone sialoprotein levels and bone metastases. J Cancer Res Ther (2011) 0.80
The role of diabetes and aging in the determinism of hypertension and the related cerebrovascular complications. Arch Gerontol Geriatr (2011) 0.80
Stabbing headache in patients with autoimmune disorders. Clin Neurol Neurosurg (2012) 0.80
Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma. Indian J Med Paediatr Oncol (2011) 0.80
Effect of L-carnitine on the size of low-density lipoprotein particles in type 2 diabetes mellitus patients treated with simvastatin. Metabolism (2009) 0.79
Radioisotopic assessment of gastric emptying of solids in elderly subjects. Aging Clin Exp Res (2006) 0.79
Tumor lysis syndrome in elderly. Crit Rev Oncol Hematol (2007) 0.79
Centenarians and supercentenarians: a black swan. Emerging social, medical and surgical problems. BMC Surg (2012) 0.79
Hypomethylating agent 5-aza-2'-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models. J Cell Physiol (2014) 0.78
Prevalence of aging-associated cognitive decline in an Italian elderly population: results from cross-sectional phase of Italian PRoject on Epidemiology of Alzheimer's disease (IPREA). Aging Clin Exp Res (2010) 0.78
Post laryngectomy speech rehabilitation outcome in elderly patients. Eur Arch Otorhinolaryngol (2013) 0.78
What is the frailty in elderly? Value and significance of the multidimensional assessments. Arch Gerontol Geriatr (2012) 0.78
Serum carnitine levels in patients with tumoral cachexia. Eur J Intern Med (2005) 0.78
Motor cortex hyperexcitability in subcortical ischemic vascular dementia. Arch Gerontol Geriatr (2010) 0.78
Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial. Metab Brain Dis (2011) 0.77
Inflammation in peripheral arterial disease (PAD). Curr Pharm Des (2012) 0.77
Efficacy of human recombinant erythropoietin plus IFN-alpha in patients affected by chronic hepatitis C. J Interferon Cytokine Res (2004) 0.77
L-carnitine reduces severity of physical and mental fatigue and improves daily activities in the elderly. South Med J (2006) 0.77
Prevalence of high ankle-brachial index (ABI) in general population of Southern Italy, risk factor profiles and systemic cardiovascular co-morbidity: an epidemiological study. Arch Gerontol Geriatr (2010) 0.77
A combination of glycosylated hemoglobin, impaired fasting glucose and waist circumference is effective in screening for individuals at risk for future type 2 diabetes. Arch Gerontol Geriatr (2009) 0.77
Can ultrasonographic findings of perihepatic lymphadenopathy promote investigations to detect possible presence of virus C infection in non-symptomatic subjects? Hepatol Res (2003) 0.77